Form 4: Accustem Sciences Inc. Director Increases Stake Through Indirect Purchases

Gabriele M. Cerrone, a director and 10% owner of Accustem Sciences Inc., has increased his indirect holdings of common stock through a series of purchases via Panetta Partners Limited.

Summary

• Gabriele M. Cerrone, a director and 10% owner of Accustem Sciences Inc. (ACUT), reported changes in beneficial ownership.
• The transactions involved the purchase of Accustem Sciences Inc. common stock indirectly through Panetta Partners Limited.
• On March 18, 2025, 100,000 shares were purchased at a price of $0.447 per share.
• On April 7, 2025, two transactions occurred: 17,802 shares were purchased at $0.609 per share, and 35,000 shares were purchased at $0.65 per share.
• Following these transactions, Cerrone's indirect beneficial ownership via Panetta Partners Limited totals 4,872,759 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director's increased investment suggests confidence, but it's a routine transaction disclosure.

Positives

• Director's increased investment may signal confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. Investors often monitor such filings for signals about management's confidence in the company's prospects.

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive sign.

Key Dates

Keywords

Accustem Sciences Inc., ACUT, Gabriele M. Cerrone, Panetta Partners Limited, Beneficial Ownership, Director, Common Stock, SEC Form 4